Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
0.7100
Dollar change
+0.0090
Percentage change
1.29
%
Index- P/E- EPS (ttm)-0.58 Insider Own15.63% Shs Outstand38.50M Perf Week-1.54%
Market Cap13.60M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float16.17M Perf Month-24.67%
Income-22.73M PEG- EPS next Q- Inst Own5.97% Short Float2.25% Perf Quarter-25.03%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio2.69 Perf Half Y-40.83%
Book/sh0.38 P/B1.88 EPS next Y- ROA-72.70% Short Interest0.36M Perf Year-54.78%
Cash/sh0.23 P/C3.11 EPS next 5Y- ROE-89.16% 52W Range0.65 - 2.10 Perf YTD-22.81%
Dividend Est.- P/FCF- EPS past 5Y-3.78% ROI-153.19% 52W High-66.19% Beta0.59
Dividend TTM- Quick Ratio2.20 Sales past 5Y0.00% Gross Margin- 52W Low9.23% ATR (14)0.05
Dividend Ex-Date- Current Ratio2.20 EPS Y/Y TTM4.07% Oper. Margin0.00% RSI (14)38.12 Volatility6.29% 7.45%
Employees- Debt/Eq0.02 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.97
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q84.51% Payout- Rel Volume1.25 Prev Close0.70
Sales Surprise- EPS Surprise78.61% Sales Q/Q- EarningsNov 15 BMO Avg Volume135.50K Price0.71
SMA20-8.70% SMA50-14.65% SMA200-34.15% Trades Volume167,651 Change1.29%
Mar-27-24 08:00AM
Mar-11-24 08:00AM
Mar-05-24 08:00AM
Feb-28-24 08:00AM
Feb-26-24 08:00AM
07:50PM Loading…
Feb-16-24 07:50PM
Feb-06-24 07:00AM
Jan-29-24 04:30PM
Jan-16-24 07:30AM
Jan-11-24 01:10PM
Dec-22-23 07:45PM
Dec-05-23 09:00AM
Nov-30-23 08:30AM
Nov-28-23 09:00AM
Nov-27-23 07:30AM
07:55AM Loading…
Nov-24-23 07:55AM
Nov-21-23 09:00AM
Nov-17-23 08:00AM
Nov-15-23 09:00AM
Nov-07-23 11:45AM
Nov-06-23 05:40PM
Oct-23-23 09:00AM
Oct-05-23 07:30AM
Oct-04-23 08:35AM
Sep-22-23 06:00AM
Sep-18-23 07:30AM
Sep-13-23 07:30AM
Aug-25-23 06:16PM
Aug-15-23 07:30AM
Aug-03-23 06:00AM
07:30AM Loading…
Aug-02-23 07:30AM
Jul-17-23 05:00PM
Jul-10-23 07:30AM
Jul-04-23 10:00AM
Jun-30-23 08:30AM
Jun-23-23 06:00AM
Jun-21-23 07:03AM
Jun-20-23 07:30AM
May-25-23 07:30AM
May-16-23 06:00AM
May-12-23 05:00PM
May-11-23 07:30AM
May-10-23 07:30AM
May-09-23 07:15AM
May-08-23 08:50AM
Apr-17-23 09:00AM
Apr-12-23 09:01AM
08:32AM
08:30AM
Mar-31-23 08:00PM
Mar-30-23 08:30AM
Mar-22-23 08:30AM
Mar-14-23 08:30AM
Mar-01-23 06:00AM
Feb-28-23 08:30AM
Feb-21-23 02:30AM
Feb-15-23 07:30AM
Feb-14-23 02:30AM
Feb-09-23 06:00AM
Feb-07-23 08:30AM
Jan-30-23 08:30AM
Jan-19-23 06:00AM
Jan-17-23 08:30AM
Jan-13-23 08:30AM
Jan-09-23 08:30AM
Jan-06-23 08:30AM
Nov-28-22 04:30PM
Nov-15-22 06:00AM
Nov-10-22 09:00AM
Sep-29-22 08:30AM
Sep-12-22 08:30AM
Sep-06-22 08:30AM
Jul-13-22 08:30AM
Jun-27-22 08:30AM
Jun-01-22 06:00AM
May-31-22 08:30AM
May-24-22 08:30AM
May-11-22 06:00AM
May-10-22 03:00AM
May-06-22 10:41AM
May-02-22 03:30AM
Apr-21-22 08:30AM
Apr-08-22 08:30AM
Apr-06-22 08:30AM
Mar-31-22 09:30AM
Mar-15-22 03:30AM
Feb-28-22 03:10AM
Feb-25-22 08:30AM
Jan-20-22 03:30AM
Jan-18-22 03:30AM
Jan-04-22 03:30AM
Dec-30-21 03:30AM
Dec-09-21 08:00AM
Dec-03-21 08:43AM
03:05AM
Dec-02-21 04:55PM
08:00AM
Nov-16-21 08:30AM
Oct-19-21 08:30AM
Oct-18-21 08:35AM
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz on October 20, 1994 and is headquartered in Toronto, Canada.